×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CRBP – corbus pharmaceuticals holdings, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CRBP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/28
08:00 am
crbp
Corbus Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Study of Next-Generation CB1 Inverse Agonist CRB-913 for the Treatment of Obesity
Medium
Report
Corbus Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Study of Next-Generation CB1 Inverse Agonist CRB-913 for the Treatment of Obesity
3/18
08:08 pm
crbp
BMO Hosts Second Annual Obesity Summit on the Future of the GLP-1+ Market [Yahoo! Finance]
Medium
Report
BMO Hosts Second Annual Obesity Summit on the Future of the GLP-1+ Market [Yahoo! Finance]
3/18
08:44 am
crbp
BMO Hosts Second Annual Obesity Summit on the Future of the GLP-1+ Market [Globe and Mail, The (Toronto, Canada)]
High
Report
BMO Hosts Second Annual Obesity Summit on the Future of the GLP-1+ Market [Globe and Mail, The (Toronto, Canada)]
3/12
12:08 pm
crbp
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $51.00 price target on the stock.
Low
Report
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $51.00 price target on the stock.
3/12
08:05 am
crbp
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock, down previously from $75.00.
Low
Report
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock, down previously from $75.00.
3/11
03:17 pm
crbp
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its price target lowered by analysts at Jefferies Financial Group Inc. from $70.00 to $53.00. They now have a "buy" rating on the stock.
Low
Report
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its price target lowered by analysts at Jefferies Financial Group Inc. from $70.00 to $53.00. They now have a "buy" rating on the stock.
3/11
08:06 am
crbp
Corbus Pharmaceuticals Reports Q4 and 2024 Financial Results and Provides a Corporate Update [Yahoo! Finance]
Medium
Report
Corbus Pharmaceuticals Reports Q4 and 2024 Financial Results and Provides a Corporate Update [Yahoo! Finance]
3/11
08:00 am
crbp
Corbus Pharmaceuticals Reports Q4 and 2024 Financial Results and Provides a Corporate Update
Low
Report
Corbus Pharmaceuticals Reports Q4 and 2024 Financial Results and Provides a Corporate Update
Date
Time
Symbol
Company Name
Action
%Chg
3/11/2025
08:00 am
crbp
corbus pharmaceuticals holdings, inc.
BEAT
Report
-2.1%
corbus pharmaceuticals holdings, inc.
3/11/2025
08:00 am
crbp
corbus pharmaceuticals holdings, inc.
BEAT
Report
-2.1%
corbus pharmaceuticals holdings, inc.
3/11/2025
08:00 am
crbp
corbus pharmaceuticals holdings, inc.
BEAT
Report
3.1%
corbus pharmaceuticals holdings, inc.
3/11/2025
08:00 am
crbp
corbus pharmaceuticals holdings, inc.
BEAT
Report
3.1%
corbus pharmaceuticals holdings, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/21
04:40 pm
crbp
Form 8-K Corbus Pharmaceuticals For: Mar 20
Low
Report
Form 8-K Corbus Pharmaceuticals For: Mar 20
3/18
04:45 pm
crbp
Form 3 Corbus Pharmaceuticals For: Mar 13 Filed by: Hodgson Ian
Medium
Report
Form 3 Corbus Pharmaceuticals For: Mar 13 Filed by: Hodgson Ian
3/18
04:30 pm
crbp
Form 8-K Corbus Pharmaceuticals For: Mar 13
Medium
Report
Form 8-K Corbus Pharmaceuticals For: Mar 13
3/11
05:24 pm
crbp
Form 10-K Corbus Pharmaceuticals For: Dec 31
Low
Report
Form 10-K Corbus Pharmaceuticals For: Dec 31
3/11
08:30 am
crbp
Form 8-K Corbus Pharmaceuticals For: Mar 11
Medium
Report
Form 8-K Corbus Pharmaceuticals For: Mar 11
3/7
04:30 pm
crbp
Form 4 Corbus Pharmaceuticals For: Mar 06 Filed by: Smethurst Dominic
Low
Report
Form 4 Corbus Pharmaceuticals For: Mar 06 Filed by: Smethurst Dominic
3/6
04:03 pm
crbp
Form 144 Corbus Pharmaceuticals Filed by: Smethurst Dominic
Low
Report
Form 144 Corbus Pharmaceuticals Filed by: Smethurst Dominic
2/18
05:41 pm
crbp
Form 4 Corbus Pharmaceuticals For: Feb 14 Filed by: Moran Sean F.
Medium
Report
Form 4 Corbus Pharmaceuticals For: Feb 14 Filed by: Moran Sean F.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/16
Form 10-K Corbus Pharmaceuticals For: Dec 31
23.8%
3/26 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) is now covered by analysts at Nomura. They set a "buy" rating and a $112.00 price target on the stock. 12.7%
3/12 Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q4 2019 Earnings Call Transcript [The Motley Fool] 11.8%
3/18 Form 4 Corbus Pharmaceuticals For: Mar 17 Filed by: Millian Craig Stuart 10.0%
3/9 Form 4 Corbus Pharmaceuticals For: Mar 06 Filed by: Moran Sean F. 9.6%
3/18 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 9.3%
4/9 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 8.7%
5/10 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock. 5.2%
3/28 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 5.0%
1/14 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 4.8%
3/26 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) is now covered by analysts at Nomura. They set a "buy" rating and a $112.00 price target on the stock. 12.7%
3/12 Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q4 2019 Earnings Call Transcript [The Motley Fool] 11.8%
3/18 Form 4 Corbus Pharmaceuticals For: Mar 17 Filed by: Millian Craig Stuart 10.0%
3/9 Form 4 Corbus Pharmaceuticals For: Mar 06 Filed by: Moran Sean F. 9.6%
3/18 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 9.3%
4/9 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 8.7%
5/10 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock. 5.2%
3/28 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 5.0%
1/14 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 4.8%
TOP News Decliners
12/9
Corbus Pharmaceuticals to Host Expert Symposium on the Therapeutic Potential of Targeting the Endocannabinoid System
-9.1%
5/9 Q1/2019 3/31/2019 EPS -0.430 ZacksConsensus 0.020 ActVsEst (0.450) - Miss -8.9%
8/8 Form 8-K Corbus Pharmaceuticals For: Aug 08 -8.7%
2/26 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $5.75 price target on the stock. -8.5%
11/7 Q3/2019 9/30/2019 EPS -0.320 ZacksConsensus -0.360 ActVsEst 0.040 - Beat -8.0%
3/12 Q4/2019 12/31/2019 EPS -0.410 ZacksConsensus -0.340 ActVsEst (0.070) - Miss -7.3%
3/10 Form 4 Corbus Pharmaceuticals For: Mar 06 Filed by: Salzmann Peter -6.8%
2/6 Corbus Pharmaceuticals Announces Proposed Public Offering of Common Stock -6.4%
8/13 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $7.00 price target on the stock. -6.2%
3/5 Corbus Pharmaceuticals to Report Fourth Quarter and Year-End 2019 Results on March 12, 2020 -6.1%
5/9 Q1/2019 3/31/2019 EPS -0.430 ZacksConsensus 0.020 ActVsEst (0.450) - Miss -8.9%
8/8 Form 8-K Corbus Pharmaceuticals For: Aug 08 -8.7%
2/26 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $5.75 price target on the stock. -8.5%
11/7 Q3/2019 9/30/2019 EPS -0.320 ZacksConsensus -0.360 ActVsEst 0.040 - Beat -8.0%
3/12 Q4/2019 12/31/2019 EPS -0.410 ZacksConsensus -0.340 ActVsEst (0.070) - Miss -7.3%
3/10 Form 4 Corbus Pharmaceuticals For: Mar 06 Filed by: Salzmann Peter -6.8%
2/6 Corbus Pharmaceuticals Announces Proposed Public Offering of Common Stock -6.4%
8/13 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $7.00 price target on the stock. -6.2%
3/5 Corbus Pharmaceuticals to Report Fourth Quarter and Year-End 2019 Results on March 12, 2020 -6.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: